Suiseng Diff/A ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

suiseng diff/a

laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - svín - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.

Suiseng Vet Stungulyf, dreifa আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

suiseng vet stungulyf, dreifa

laboratorios hipra s.a.* - escherichia coli f4ab fimbrial adhesin; escherichia coli f4ac fimbrial adhesin; escherichia coli f5 fimbrial adhesin; escherichia coli f6 fimbrial adhesin; escherichia coli lt enterotoxoid; clostridium perfringens type-c beta toxoid; clostridium novyi toxoid - stungulyf, dreifa

Suiseng Coli/C (Coliseng C) Stungulyf, dreifa আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

suiseng coli/c (coliseng c) stungulyf, dreifa

laboratorios hipra s.a. - escherichia coli, fimbrial adhesin f4ab; escherichia coli, fimbrial adhesin f4ac; escherichia coli, fimbrial adhesin f5; escherichia coli, fimbrial adhesin f6; escherichia coli, purified lt toxin; clostridium perfringens type-c beta toxoid; clostridium novyi, type b, alpha toxoid - stungulyf, dreifa

BindRen ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

bindren

mitsubishi pharma europe ltd - colestilan - hyperphosphatemia - lyf til að meðhöndla blóðkalíumhækkun og blóðfosfatíumlækkun - meðferð við blóðfosfatskorti hjá fullorðnum sjúklingum með stigs nýrnasjúkdóms stig 5 sem fá blóðskilun eða kviðskilun.